Drug shortages: why they keep happening, and how to actually track one that affects you

Drug shortages in the U.S. have shifted from occasional disruptions to a recurring, structural feature of the pharmaceutical supply chain, with dozens of active shortages tracked by the FDA and professional pharmacy organizations at any given time, spanning generic injectable drugs, certain chemotherapy agents, ADHD stimulant medications, and periodically, GLP-1 drugs during periods of surging demand outpacing manufacturing capacity.

The structural causes are largely economic rather than reflecting any single company's failure: many of the drugs most prone to shortage are older, low-margin generics, particularly injectables requiring more complex manufacturing, where thin profit margins have driven consolidation to just one or two manufacturers for some products — meaning a single manufacturing quality issue, facility shutdown, or raw material supply disruption at one plant can cause a genuine, difficult-to-quickly-resolve national shortage with limited backup capacity elsewhere in the supply chain.

For patients, the FDA maintains a public, regularly updated drug shortage database that pharmacies and patients can check directly for a specific medication's shortage status and expected resolution timeline where available, and the American Society of Health-System Pharmacists maintains a similarly detailed, frequently cited shortage tracking resource used heavily by hospital and retail pharmacies for supply planning.

For anyone on a medication currently in shortage or at elevated shortage risk — a category that includes many essential generic drugs without a ready substitute — asking a pharmacist proactively about the medication's current shortage status, and discussing a backup plan with the prescribing physician before a refill is actually denied at the pharmacy counter, is more effective than discovering the shortage only when a scheduled refill unexpectedly can't be filled.